back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-08 11:48 Tx date 2026-09-04 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-146,160
-12,000 vol $12.18 each |
9,519 | |
| Filed 2026-09-08 11:47 Tx date 2026-09-04 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,519 | |
| Filed 2026-08-04 11:02 Tx date 2026-08-03 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,351 | |
| Filed 2026-07-03 11:30 Tx date 2026-07-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,183 | |
| Filed 2026-06-04 13:09 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,015 | |
| Filed 2026-05-05 11:12 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
20,847 | |
| Filed 2026-04-02 17:36 Tx date 2026-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$692,400
+120,000 vol $5.77 each |
270,000 | |
| Filed 2026-04-01 12:52 Tx date 2026-03-31 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+20,679 vol |
20,679 | |
| Filed 2026-04-01 12:52 Tx date 2024-10-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-14 14:01 Tx date 2024-11-13 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$634,500
+150,000 vol $4.23 each |
150,000 | |
| Filed 2024-11-14 14:00 Tx date 2024-10-28 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|